OEI #86-87: Publishing Practices, Publishing Poetics, Edited by Jonas (J) Magnusson & Cecilia Grönberg, OEI Editör, Stockholm, 2020 [rile*, Bruxelles-Brussel]
33 notes
·
View notes
camden art centre, london / public knowledge: 'oei' / october 27
camden art centre, london / public knowledge: ‘oei’ / october 27
Camden Art Centre / Public Knowledge: OEI / October 27 / 19:00–21:00
Thursday October 27, 19:00-21:00
Camden Art Centre
Arkwright Road
London NW3 6DG
United Kingdom
This episode of Public Knowledge will comprise of a temporary display of publications and related ephemera by Jonas (J) Magnusson and Cecilia Grönberg.
Jonas (J) Magnusson and Cecilia Grönberg are the founders of OEI, a…
View On WordPress
0 notes
I've been a fan of the Swedish magazine OEI for the past many years, so it's a special pleasure to find myself included in an issue. Each issue is a humongous treasure torve of visual and text based work bursting with everything from unfamiliar contemporary artist to rare historical materials that are difficult to find. An often used series of double and triple volumes that take up several meters of shelving in my home. And now I'm so happy that, with the help of mathias Kokholm, I have managed to sneak a few pages into "OEI #94-95: geografer" based on the djurs archipelago project. Nästa nummer av OEI, #94-95, är ett 464-sidigt nummer om geografier som utkommer i början av mars. Det omfattar arbeten av och om Gunnar Olsson, Élisée Reclus, Pjotr Kropotkin, Doreen Massey, David Harvey, Christina Kullberg, Minna Henriksson, Erik Bryngelsson, Bureau d´Études, Raymond Williams, Carla Zaccagnini & Santiago Costantino, Trevor Paglen, Peder Alexis Olsson, Hérodote, Antipode, Eva Arnqvist, Aeron Bergman & Alejandra Salinas, Lytle Shaw, Jasna Jaksić, Bogdanka Poznanović, Radmila Iva Janković, Ivan Kožarić, Jonas (J) Magnusson, Nicolas Pesquès, Johannes Fridholm, Strabon, Johan Redin, Ptolemaios, Gustav Sjöberg, Edmund Husserl, Michael Marder, Georges Bataille, Katja Aglert, Filip Lindberg, Raketa, Minus Miele, Augustin Berque, Christian Abrahamsson, Alexander von Humboldt, Franz Boas, Runo Lagomarsino, Alfred Wegener, Jonathan Brott, Klaus Dodds, Louis Marin, Edwin Abbott Abbott, Anna Enström, Immanuel Kant, Axel Andersson, Mary Hunter Austin, Johanna Adolfsson, Mattias Legnér, FRAUD (Audrey Samson & Francisco Gallardo), Aihwa Ong, Emmeli Person, Bronwyn Bailey-Charteris, Pontus Pettersson, Mattias Jacobsson, Michel Chaillou, Cecilia Grönberg, Lasse Krog Møller, Kristoffer Ørum, Erika Arzt & Juan Linares, Martin Grennberger, Bo Anders Persson, Buckminster Fuller, Glenn Gould, Indigenous Peoples Atlas Of Canada #oeimagazine #djursarchipelago #geography #mapping (at Djursland) https://www.instagram.com/p/CZfYNIiMZpo/?utm_medium=tumblr
0 notes
Charles Bernstein (2008) in 39 Pressbilder från OEI Editör, Cecilia Grönberg, 2018
1 note
·
View note
NeuroVive Presents Positive Preclinical Data in Hepatocellular Cancer at HCC Summit
LUND, Sweden, Jan. 19, 2017 /PRNewswire/ -- NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF), the mitochondrial medicine company, today announced that an abstract with novel preclinical cancer data related to the company's sanglifehrin-based compounds has been accepted for presentation at the scientific conference EASL HCC Summit to take place in Geneva, Switzerland, 2-5 February, 2017.
NeuroVive has utilized its expertise in mitochondrial medicine to explore a unique aspect of the company's sanglifehrin-based compounds. In preclinical studies, the NeuroVive research team and its international collaborators have shown that a sub-set of these compounds exert unexpectedly potent anticancer effects. An abstract with the title Preclinical analysis of sanglifehrin-based cyclophilin inhibitors showing potential for treatment of hepatocellular carcinoma1 will be presented at the conference.
"We are now adding the exciting and challenging cancer area to our portfolio, expanding our core competence field within mitochondrial medicine. The addition of Dr. Michele Tavecchio to our team has accelerated the internal development process in this area, and the team has done a great job in exploring this new therapeutic opportunity for the company's sanglifehrin-based compounds", said Magnus Hansson, Chief Medical Officer at NeuroVive.
The hepatocellular cancer indication has a highPhoto - http://ift.tt/2itEvIQ medical need for new and effective treatment alternatives. The EASL HCC Summit covers topics such as early detection, diagnosis and treatment of hepatocellular carcinoma, highlighting both the basic science and clinical science aspects of this important and rapidly evolving field.
About Hepatocellular Carcinoma (HCC)
Liver cancer includes two major types: hepatocellular carcinoma (HCC) and intrahepatic bile duct cancer. Infection with certain types of the hepatitis virus increases the risk of liver cancer. Patients with alcohol or fatty liver disease (non-alcoholic steatohepatitis, NASH) induced liver cirrhosis also have an increased risk of developing cancer in the liver. Even though less common in northern Europe and the US, HCC is the sixth most prevalent cancer and the third leading cause of cancer-related deaths worldwide2,3.
1. Michele Tavecchio*, Alvar Grönberg*, Eskil Elmér*, Philippe Gallay**, Matthew Gregory***, Steven Moss ***, Magnus Hansson*. *NeuroVive Pharmaceutical, Sweden, **The Scripps Research Institute, US, ***Isomerase Therapeutics Ltd, UK.
2. Altekruse SF, McGlynn KA, Reichman ME: Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 27 (9): 1485-91, 2009.
3. Forner A, Llovet JM, Bruix J: Hepatocellular carcinoma. Lancet 379 (9822): 1245-55, 2012.
About NeuroVive
NeuroVive Pharmaceutical AB is a leader in mitochondrial medicine. The company is committed to the discovery and development of medicines that preserve mitochondrial integrity and function in areas of unmet medical need. The company's strategy is to take drugs for rare diseases through clinical development and into the market. The strategy for projects within larger indications outside the core focus area is out-licensing in the preclinical phase. NeuroVive enhances the value of its projects in an organization that includes strong international partnerships and a network of mitochondrial research institutions, as well as expertise with capacities within drug development and production.
NeuroVive has a project in early clinical phase II development for the prevention of moderate to severe traumatic brain injury (NeuroSTAT®). NeuroSTAT has orphan drug designation in Europe and in the US. The R&D portfolio consists of several late stage research programs in areas ranging from genetic mitochondrial disorders to cancer and metabolic diseases such as NASH.
NeuroVive is listed on Nasdaq Stockholm, Sweden (ticker: NVP). The share is also traded on the OTCQX Best Market in the US (OTC: NEVPF).
For investor relations and media questions, please contact:
Cecilia Hofvander, NeuroVive, Tel: +46 (0)46 275 62 21 or
[email protected]
Charles Athle Nelson, NeuroVive US representative, Tel +1 212 961 6277 or
[email protected]
NeuroVive Pharmaceutical AB (publ)
Medicon Village, SE-223 81 Lund, Sweden
Tel: +46 (0)46 275 62 20 (switchboard)
This information is information that NeuroVive Pharmaceutical AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 10:00 a.m. CET on January 19, 2017.
CONTACT:
This information was brought to you by Cision http://news.cision.com
http://ift.tt/2jqVZUx
The following files are available for download:
http://ift.tt/2jAVzgT
NeuroVive presents positive preclinical data in hepatocellular cancer at HCC Summit
Read this news on PR Newswire Asia website: NeuroVive Presents Positive Preclinical Data in Hepatocellular Cancer at HCC Summit
0 notes
11 notes
·
View notes
OEI # 90-91: Syntax & Hammer of Tautology. Concrete and Visual Poetry in Yugoslavia, 1968–1983, Edited Jonas (J) Magnusson & Cecilia Grönberg, Guest edited by Sezgin Boynik, OEI Editör, Stockholm, 2021 [rile*, Bruxelles-Brussel]
20 notes
·
View notes
OEI #100-101: GDH / fortsätta med andra medel, Edited by Jonas (J) Magnusson & Cecilia Grönberg, OEI Editör, Stockholm, 2023
(on the way of Our Polite Society)
9 notes
·
View notes
"oei", april 10 and 11: moving mountains & mounting transitions
“oei”, april 10 and 11: moving mountains & mounting transitions
Moving mountains & mounting transitions
2 days on “editorial thinking” with OEI at Index – The Swedish Contemporary Art Foundation
This event will be live-streamed via Index’ Twitch channel: www.twitch.tv/indexfoundation
Saturday April 10 and Sunday April 11, 14:00-17:00
On the occasion of the exhibition Editorial Thinking at Index, OEI magazine organizes a two-day event, inviting artists,…
View On WordPress
2 notes
·
View notes
lytle shaw, jonas (j) magnusson & cecilia grönberg on fieldworks, locality, and alternative histories
lytle shaw, jonas (j) magnusson & cecilia grönberg on fieldworks, locality, and alternative histories
Wednesday 17/11 Gothenburg
Lytle Shaw, Jonas (J) Magnusson & Cecilia Grönberg on fieldworks, locality, and alternative histories
New York based writer Lytle Shaw will talk about his recent book New Grounds for Dutch Landscape (OEI editör, 2021), where he uses an experimental, site-specific method to demonstrate how 17th century Dutch painters did not so much represent the newly made landscape of…
View On WordPress
0 notes
oei (sweden)
invito a conoscere le edizioni svedesi – internazionali – OEI (attraverso il loro sito): quasi cento numeri della rivista, moltissimi dei quali in inglese; e monografie di arte contemporanea, scritture di ricerca, materiali verbovisivi, design, territorio, editoria. dal mondo intero (Italia inclusa).
OEI _ Jonas (J) Magnusson & Cecilia Grönberg
http://www.oei.nu/
_
View On WordPress
0 notes
oei editions in helsinki
oei editions in helsinki
OEI at Publics, Helsinki
Friday September 24
5–7pm
Opening for the OEI exhibition:
staying with editing & localizing publishing
+ Helsinki release of OEI #90-91: Sickle of Syntax & Hammer of Tautology: Concrete and Visual Poetry in Yugoslavia, 1968-1983
Saturday September 25
12–3pm
Workshop & presentation:
OEI editors Jonas (J) Magnusson & Cecilia Grönberg on “staying with editing and localizing…
View On WordPress
0 notes
thursday march 5: release of oei # 86–87: publishing practices, publishing poetics
thursday march 5: release of oei # 86–87: publishing practices, publishing poetics
Thursday March 5: release of OEI # 86–87: publishing practices, publishing poetics (640 pages, ed. Jonas (J) Magnusson & Cecilia Grönberg) at Index – The Swedish Contemporary Art Foundation
http://www.oei.nu/w/1.html
Please join us at Index for an evening on publishing practices & publishing poetics at the occasion of the release of the new 640 page issue of OEI, # 86–87.
Bringing together…
View On WordPress
0 notes